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Factor Proline- and Glutamine-rich (Sfpq) and
Non-POU Domain-containing Octamer-binding
Protein (Nono) during Neuronal Differentiation*□S
Matthias D. Sury‡, Erik McShane‡, Luis Rodrigo Hernandez-Miranda§,
Carmen Birchmeier§, and Matthias Selbach‡¶
The c-Jun N-terminal kinase (JNK) is an important medi-
ator of physiological and pathophysiological processes in
the central nervous system. Importantly, JNK not only is
involved in neuronal cell death, but also plays a significant
role in neuronal differentiation and regeneration. For ex-
ample, nerve growth factor induces JNK-dependent neu-
ronal differentiation in several model systems. The mech-
anism by which JNK mediates neuronal differentiation is
not well understood. Here, we employed a proteomic
strategy to better characterize the function of JNK during
neuronal differentiation. We used SILAC-based quantita-
tive proteomics to identify proteins that interact with JNK
in PC12 cells in a nerve growth factor–dependent manner.
Intriguingly, we found that JNK interacted with neuronal
transport granule proteins such as Sfpq and Nono upon
NGF treatment. We validated the specificity of these in-
teractions by showing that they were disrupted by a spe-
cific peptide inhibitor that blocks the interaction of JNK
with its substrates. Immunoprecipitation and Western
blotting experiments confirmed the interaction of JNK1
with Sfpq/Nono and demonstrated that it was RNA de-
pendent. Confocal microscopy indicated that JNK1 asso-
ciated with neuronal granule proteins in the cytosol of
PC12 cells, primary cortical neurons, and P19 neuronal
cells. Finally, siRNA experiments confirmed that Sfpq was
necessary for neurite outgrowth in PC12 cells and that it
most likely acted in the same pathway as JNK. In sum-
mary, our data indicate that the interaction of JNK1 with
transport granule proteins in the cytosol of differentiating
neurons plays an important role during neuronal
development. Molecular & Cellular Proteomics 14:
10.1074/mcp.M114.039370, 50–65, 2015.
The members of the c-Jun N-terminal kinase (JNK)1 family
are important mediators of a broad range of biological pro-
cesses in the brain (1, 2). JNK belongs to the family of mito-
gen-activated protein kinases and is encoded by three differ-
ent genes: jnk1, jnk2, and jnk3. Alternative splicing combined
with alternative exon usage of the three genes leads to at least
10 different JNK isoforms (3). JNK is induced by various
stimuli such as cytokines, ligands of Toll-like receptors, or
growth factors (4).
JNK is well known to induce neuronal cell death. However,
it has become clear within the past decade that JNK plays an
important role in neuronal regeneration, migration, and differ-
entiation (5–8). JNK controls dendritic microtubule assembly
and disassembly in sympathetic neurons (2, 9) and is respon-
sible for dendritic elongation during brain development in
mice (10). Furthermore, several cytoskeleton-regulating pro-
teins such as doublecortin, superior cervical ganglion-10 pro-
tein, microtubule-associated protein 1B, microtubule-associ-
ated protein 2, and MARCKS-like protein 1 have been
identified as JNK substrates (11–16). Collectively, these ob-
servations have established that JNKs not only are involved in
neuronal death, but also play an important role during differ-
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entiation and regeneration. Although stress-induced pro-apo-
ptotic JNK signaling is well characterized, the mechanisms
involved in JNK-dependent neuronal differentiation remain
enigmatic.
Quantitative mass-spectrometry-based proteomics has
emerged as a powerful technology for investigating mamma-
lian signaling pathways (17, 18). Specifically, stable isotope
labeling by amino acids in cell culture (SILAC) has been
shown to be a powerful approach for studying dynamic
changes in protein–protein interactions during cell signaling.
We reasoned that an unbiased proteomic analysis of JNK
interaction partners during neuronal differentiation could pro-
vide novel insights into the mechanisms involved. For that
purpose, we used PC12 cells as a well-characterized classical
model for neuronal differentiation (19). Stimulation of PC12
cells with nerve growth factor (NGF) induces a major shift in
phenotype, from proliferating tumor cells to non-dividing neu-
rons showing characteristics of sympathetic neurons such as
the growth of long neurites and electrical excitability (19, 20).
In PC12 cells, NGF binds to neurotrophic tyrosine kinase
receptor 1, low-affinity neurotrophin receptor, and fibroblast
growth factor receptors (21, 22). This leads to a coordinated
activation of downstream signaling cascades such as the
Ras/Raf/Erk1–2, PI3K, and JNK pathways, resulting in in-
creased expression of genes that are involved in neuronal
differentiation (23, 24). Furthermore, G-proteins including Ras,
Rap, and Cdc42 have been shown to link receptor activity to
downstream kinase activation (25–27).
Here, we used quantitative interaction proteomics to ana-
lyze dynamic changes in JNK interaction partners during
NGF-induced differentiation of PC12 cells. Our results show
that JNK dynamically interacts with G-proteins, cytoskeletal
proteins, and RNA binding proteins with distinct kinetic pat-
terns. Intriguingly, several of the identified RNA binding pro-
teins are known components of transport granules involved in
mRNA localization and localized translation in neurons. West-
ern blotting and co-localization experiments using confocal
microscopy and proximity ligation assays validated the NGF-
induced association of JNK1 with two RNA binding proteins,
Sfpq and Nono. Furthermore, Sfpq knockdown decreased
NGF-induced neurite outgrowth in PC12 cells, supporting the
hypothesis that the interaction of JNK and Sfpq may contrib-
ute to neuronal differentiation.
EXPERIMENTAL PROCEDURES
Cell Culture—The rat pheochromocytoma cell line PC12 (ATCC,
Manassas, VA) was cultured essentially as described before (19). In
brief, PC12 cells were grown at 37 °C in 5% CO2 in either 10-cm or
15-cm cell culture dishes coated with rat tail type 1 collagen (Sigma-
Aldrich, St. Louis, MO) at 30% confluency in RPMI 1640 medium
(PAA Laboratories GmbH, Pasching, Austria) containing 10% horse
serum (Invitrogen), 5% FCS (Sigma-Aldrich), 4 mM glutamine (PAA
Laboratories GmbH), 100 U/ml penicillin, and 100 g/ml streptomycin
(Invitrogen). For SILAC labeling, media contained 10% dialyzed horse
serum (produced in house with an 8000 to 10,000 molecular weight
cutoff), 5% dialyzed FCS (Sigma-Aldrich), and one of the following
Lys–Arg combinations: 48 g/ml Lys-C6H14N2O2 (Lys-0) and 28
g/ml Arg-C6H14N4O2 (Arg-0) (Sigma-Aldrich), 48 g/ml Lys-
C6H10D4N2O2 (Lys-4) and 28 g/ml Arg-
13C6H14N4O2 (Arg-6), or 48
g/ml Lys-13C6H14
15N2O2 (Lys-8) and 28 g/ml Arg-
13C6H14
15N4O2
(Arg-10) (Sigma Isotec, Miamisburg, OH). For cell differentiation,
PC12 cells were starved for 24 h in media containing 1% horse serum
or 1% dialyzed horse serum and were treated with 100 ng/ml NGF
(Sigma-Aldrich) for the indicated length of time. For JNK inhibition
experiments, PC12 cells were pretreated for 1 h with 10 M SP600125
(Calbiochem, San Diego, CA), 10 M D-JNKI-1, or 10 M control
peptide D-TAT (Enzo Life Sciences, Lo¨rrach, Germany).
Primary cortical neurons were prepared from E18.5 mouse em-
bryos as described elsewhere (28). Briefly, cortices were dissected in
Hanks solution under a stereomicroscope and dissociated enzymat-
ically in neurobasal medium (Invitrogen) containing 0.1% trypsin
(Sigma-Aldrich) and 0.001% DNaseI (Roche) at 37 °C for 15 min.
Trypsin was inactivated by 10% FBS in neurobasal media at 37 °C for
5 min, and cells were dissociated by trituration with a sterile pipette
tip. The resulting suspension was centrifuged at 1000  g for 3 min,
and the supernatant was discarded. Next, neurons were resuspended
and plated in neurobasal media containing B27 supplement (Invitro-
gen) and 100 g/ml penicillin/streptomycin. Neurons were cultured
for 4, 6, 8, 12, 24, 36, and 48 h.
Cell suspensions of the murine teratocarcinoma cell line P19
(ATCC) were cultured for 4 days in DMEM containing 5% FBS, 1 mM
retinoic acid (Sigma), and 100 g/ml penicillin/streptomycin. Subse-
quently, aggregates of P19 cells were dissociated enzymatically in
DMEM (Invitrogen) containing 0.25% trypsin and 0.001% DNaseI at
37 °C for 10 min. Trypsin was inactivated by 10% FBS in DMEM at
37 °C for 5 min, and cells were dissociated by trituration with a sterile
pipette tip. Afterward, cells were resuspended and plated in DMEM
containing 5% FBS and 100 g/ml penicillin/streptomycin for 2 days.
48 h after plating, cells were treated for an additional 24 h with 10 M
ARAC (Sigma) to eliminate proliferating glial-like cells. Last, P19-
differentiated neurons were enzymatically dissociated and plated in
DMEM containing 5% FBS and 100 g/ml penicillin/streptomycin.
Neurons were cultured for 4, 6, 8, 12, 24, 36, and 48 h.
Quantification of Neurite Outgrowth—Neurites of PC12 cells were
measured essentially as described elsewhere (29, 30). PC12 cells
were grown in six-well plates, and five pictures per well were ran-
domly taken 24 h after treatment using a camera (Canon, Krefeld,
Germany) linked to an inverted microscope with phase contrast illu-
mination (Olympus, Hamburg, Germany). Each visual field contained
on average 40 living cells. The number of neurites per visual field was
measured using Adobe Photoshop (Adobe Systems, San Jose, CA).
This number was divided by the total number of cells per visual field
and expressed either as the percentage of untreated cells or as the
percent inhibition of NGF-treated cells within the corresponding
experiment.
Immunoblot Analysis—PC12 cells were lysed for 30 min on ice in
modified radio-immunoprecipitation buffer (50 mM Tris HCl, pH 7.4,
150 mM NaCl, 1% Nonidet P-40, 0.25% Na-deoxycholate, 1 mM
EDTA) containing 0.1% SDS and the following inhibitors: 1 protease
inhibitor mixture (Roche), 1 mM sodium orthovanadate, 20 mM sodium
pyrophosphate, and 1 phosphatase inhibitor mixture 1 (Sigma-
Aldrich). The preparation of nuclear and cytosolic extracts was per-
formed as described elsewhere (31). In brief, PC12 cells were incu-
bated in a hypotonic buffer containing 10 mM HEPES (pH 7.9), 10 mM
KCl, 0.1 mM EDTA, 0.1 mM EGTA, 0.025% Nonidet P-40 to extract
cytosolic proteins. Afterward, nuclear proteins were extracted with a
hypertonic buffer containing 20 mM HEPES (pH 7.9), 400 mM NaCl, 1
mM EDTA, 1 mM EGTA. The protein concentration was determined
using the Coomassie Plus Protein Assay Kit (Pierce, Rockford, IL).
Equal amounts of protein were boiled in LDS sample buffer (Invitro-
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gen) under reducing conditions and separated on a 4–12% NuPAGE
gradient gel (Invitrogen) according to the manufacturer’s instructions.
After blotting onto a PVDF membrane, nonspecific binding sites were
blocked for 1 h with 5% non-fat dry milk (Carl Roth, Karlsruhe,
Germany) in Tris-buffered saline containing 0.1% Tween 20. The
membrane was incubated overnight using antibodies against phos-
pho-JNK Thr183/Tyr185, phospho-c-Jun Ser73, c-Jun (Cell Signaling
Technologies, Beverly, MA), pan-JNK, Sfpq, Nono (Santa Cruz Bio-
technology, Santa Cruz, CA), JNK1 (BD Biosciences, Franklin Lakes,
NJ), and JNK2 (Novus Biologicals, Littleton, CO). Horseradish-perox-
idase-conjugated sheep anti-mouse antibody and donkey anti-rabbit
(GE Healthcare, Buckinghamshire, UK) were used as secondary an-
tibodies. To verify that equal amounts of protein were loaded, mem-
branes were incubated at 37 °C for 20 min in stripping buffer (62.5 mM
Tris (pH 6.7), 2% SDS, 100 mM -mercaptoethanol) and reprobed
with an antibody against -actin (Sigma-Aldrich). Blots were incu-
bated with enhanced chemiluminescence substrate (PerkinElmer,
Waltham, MA), and band intensities were measured and quantified
using Scion Image 4.0 (Scion Corporation, Frederick, MD).
Immunoprecipitation—For immunoprecipitation followed by LC-
MS/MS analysis, PC12 cells were lysed for 10 min on ice in 50 mM Tris
HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.25% sodium deoxy-
cholate, 1 mM EDTA, and all the protease and phosphatase inhibitors
as described above. The protein concentration was determined using
the Coomassie Plus Protein Assay Kit (Pierce). JNK1 (Biovision, Mil-
pitas, CA) and JNK2 (Novus Biologicals) were incubated for 1 h at
4 °C with protein A Sepharose beads (Biovision) and then cross-
linked for 1 h at room temperature in 200 mM sodium borate (pH 9.0),
25 mM dimethyl pimelimidate (Sigma-Aldrich). After three washes in
200 mM sodium borate, the antibody–bead complexes were blocked
in 200 mM ethanolamine (pH 8.0) for 2 h at 4 °C. Equal amounts of
protein extracts were incubated with bead-coupled antibody over-
night at 4 °C. After two washes with lysis buffer and one with 5 mM
Tris HCl (pH 7.4), proteins were eluted with 100 mM glycine (pH 3.0).
For immunoprecipitation followed by immunoblot analysis, cells were
lysed for 30 min on ice in 20 mM HEPES (pH 7.9), 400 mM NaCl,
0.025% Nonidet P-40, 1 mM EDTA, 1 mM EGTA, and all the protease
and phosphatase inhibitors as described above. The protein concen-
tration was determined using the Coomassie Plus Protein Assay Kit
(Pierce). JNK1/3 or Nono antibody (both from Santa Cruz Biotechnol-
ogy) was bound to protein A Sepharose beads (Biovision) in PBS for
3 h at 4 °C. Equal amounts of protein extracts were incubated with
bead-coupled antibody in lysis buffer without Nonidet P-40 overnight
at 4 °C. After three washes with lysis buffer without Nonidet P-40,
samples were boiled in LDS sample buffer (Invitrogen) and further
processed via immunoblot analysis as described above.
Sample Preparation for LC-MS/MS—Eluted proteins from JNK1/2
immunoprecipitation were precipitated in EtOH, 133 mM sodium ac-
etate (pH 5.0), 0.06% GlycoBlue (Ambion Invitrogen Ltd., Paisley, UK)
overnight at 4 °C. After centrifugation, the protein pellet was dried and
dissolved in 10 mM HEPES (pH 8.0), 6 M urea, 2 M thiourea and
reduced with 10 mM DTT in 50 mM ammonium bicarbonate. Proteins
were alkylated in 50 mM ammonium bicarbonate, 55 mM iodacet-
amide, pre-digested with Lysyl endopeptidase (LysC) (Wako, Osaka,
Japan), and subjected to trypsin digestion (Promega) overnight. Di-
gestion was stopped by trifluoroacetic acid. Stop-and-go extraction
(STAGE) tips containing C18 empore disks (3M, Minneapolis, MN)
were used to purify and store peptide extracts (32).
LC-MS/MS—LC-MS/MS analysis was performed as described
previously (33). Peptide mixtures were separated via reversed phase
chromatography using the Eksigent NanoLC-1D Plus system (Eksi-
gent, Dublin, CA) on in-house-manufactured 10-cm fritless silica mi-
crocolumns with an inner diameter of 75 m. Columns were packed
with ReproSil-Pur C18-AQ 3-m resin (Dr. Maisch GmbH, Ammer-
buch, Germany) (34). Separation was performed using a 10% to 60%
acetonitrile gradient (155 min) with 0.5% acetic acid at a flow rate of
200 nl/min. Eluting peptides were directly ionized via electrospray
ionization and transferred into the orifice of an LTQ-Orbitrap hybrid
mass spectrometer (Thermo Fisher, Waltham, MA). Mass spectrom-
etry was performed in the data-dependent mode with one full scan in
the Orbitrap (m/z  300–1700; r  60,000; target value  1  106).
The five most intense ions with a charge state greater than 1 were
selected (target value  5000; monoisotopic precursor selection en-
abled) and fragmented in the LTQ using collision-induced dissociation
(35% normalized collision energy, wideband activation enabled). The
dynamic exclusion for selected precursor ions was 60 s.
MS Data Processing—The MaxQuant software package (version
1.3.0.5) was used to identify and quantify proteins (35). SILAC triplets
or duplets were quantified using the following settings: heavy-label
Lys-8, Arg-10 and Lys-4, Arg-6; a maximum of three labeled amino
acids per peptide; and top 10 MS/MS peaks per 100 Da. Carbam-
idomethylation of cysteine was selected as a fixed modification, and
oxidation of methionine and acetylation of the protein N terminus
were used as variable modifications. Trypsin was selected as the
protease (full specificity) with a maximum of two missed cleavages.
MS/MS spectra were searched using the Andromeda search engine
(36) against a UniProt rat database (release 2012–06, 37,327 entries)
with an additional 248 common contaminants. All protein se-
quences were also reversed to generate a target-decoy database.
A first search with a precursor mass tolerance of 20 ppm was used,
and the main search was performed with a mass tolerance of 6 ppm
(37). A mass tolerance of 20 ppm was selected for fragment ions. A
minimum of six amino acids per identified peptide and at least one
peptide per protein group were required. The false discovery rate
was set at 1% at both the peptide and the protein level. Protein
ratios were calculated from the median of all normalized peptide
ratios using only unique peptides or peptides assigned to the
protein group with the greatest number of peptides (razor peptides).
Only protein groups with at least three SILAC counts were consid-
ered for further analysis.
Immunofluorescence Analysis—PC12 cells were incubated on
poly-l-lysine-coated glass coverslips, fixed with 4% paraformalde-
hyde, and blocked for 1 h in PBS containing 10% goat serum and
0.3% Triton-X 100. The cells were incubated at a dilution of 1:500 with
antibodies against JNK1 (Novus Biologicals), Nono, and Sfpq (Santa
Cruz Biotechnology) overnight at 4 °C. Alexa Fluor 488 goat anti-
rabbit IgG and Alexa Fluor 568 goat anti-mouse IgG (Invitrogen) were
used as secondary antibodies at a dilution of 1:1000. PC12 cells were
counterstained with DAPI and mounted with ProLong Gold Antifade
(Invitrogen). Nonspecific staining was assessed through incubation of
cells in the absence of primary antibodies. Images were taken with a
Leica TCS SP5 confocal microscope (Leica Microsystems, Wetzlar,
Germany) using a 63 objective and recorded by Leica LAS AF
software. Images were processed using Adobe Photoshop (Adobe
Systems). P19 neuronal cells and primary cortical neurons were fixed
with 4% paraformaldehyde in 0.1 M sodium phosphate buffer (pH 7.4).
Primary antibodies against JNK1, Sfpq (as described above), and
doublecortin (1:2000; Santa Cruz) were used. Secondary antibodies
conjugated to Cy2, Cy3, or Cy5 were used at a dilution of 1:500
(Jackson ImmunoResearch Laboratories, Suffolk, UK). Fluorescence
was imaged with a 63 objective on a Zeiss LSM 700 confocal
microscope, and images were processed using Adobe Photoshop
software. Primary cortical and P19 neuronal cultures were visualized
with a 40 objective, and co-localization signals of JNK1 and Sfpq
were quantified on at least 10 randomly taken visual fields containing
15 to 20 cells each.
Proximity Ligation Assay—PC12 cells were incubated on poly-l-
lysine-coated 18-well -Slides (ibidi, Martinsried, Germany) and then
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subjected to primary antibody incubation as described above. The
interactions between Sfpq-Nono and JNK1-Sfpq were assessed us-
ing the Duolink proximity ligation assay (Olink, Uppsala, Sweden)
according to the manufacturer’s instructions. Images were taken with
a Leica TCS SP5 confocal microscope (Leica Microsystems) using a
63 objective. Fluorescence spots were counted using ImageJ soft-
ware (National Institutes of Health). Negative controls using JNK1
antibody alone with both secondary antibodies or secondary antibod-
ies only did not show any signal.
siRNA Transfection—Transfection was carried out using the Amaxa
Cell Line Nucleofector system according to the manufacturer’s in-
structions with PC12-cell-specific settings (Lonza, Cologne, Ger-
many). In brief, 2  106 cells were transfected with 200 nmol Sfpq
siRNA (Thermo Fisher) and seeded in a six-well plate. After 4 days,
cells were starved for 24 h and then differentiated as described
above. Sfpq knockdown efficiency was confirmed by immunoblot
before NGF treatment.
Statistical Analysis—Band intensities of Western blots were evalu-
ated densitometrically using Scion Image 4.0 (Scion Corporation) and
are expressed as a percentage relative to unstimulated cells (“relative
pixel density”). Comparisons between multiple groups were per-
formed via one-way analysis of variance followed by a Bonferroni post
hoc test, and comparisons between two groups were assessed via
the standard Student’s t test (Prism 4.0, GraphPad Software, San
Diego, CA). All data are expressed as mean  S.E. Differences were
considered statistically significant at p  0.05. Cluster analysis was
performed using Perseus (MPI, Munich, Germany) and PANTHER
molecular function terms in the DAVID bioinformatics database (DA-
VID Bioinformatics Resources, National Cancer Institute, Frederick,
MD) (38).
RESULTS
Nerve Growth Factor Induces JNK-dependent Neurite Out-
growth in PC12 Cells—In order to study JNK interaction part-
ners during neuronal differentiation via quantitative mass
spectrometry, we decided to use the very well-characterized
rat pheochromocytoma cell line PC12 (19). The hallmark of
PC12 cells is that treatment with NGF induces a major shift in
phenotype, from proliferating tumor cells to non-dividing neu-
rons. For our proteomics experiments, PC12 cells were grown
in SILAC media containing dialyzed horse and calf sera and
lower concentrations of lysine and arginine than in standard
RPMI media. 24 h before differentiation, cells were starved in
SILAC media containing 1% dialyzed horse serum. To assess
the role of JNK in NGF-induced neuronal differentiation, we
stimulated PC12 cells with a single dose of NGF (100 ng/ml) in
the presence or absence of the ATP-competitive JNK inhibitor
SP600125 (Fig. 1A). Without the inhibitor, NGF-induced neu-
rite outgrowth was clearly visible at both 6 and 24 h after
stimulation. When NGF was not replenished, neurites were
largely degenerated after 48 h. Pretreatment of cells with
SP600125 decreased NGF-induced neurite outgrowth by
60% at 6 h and 24 h. This result is in line with previous
studies showing that JNK is an important mediator for neu-
ronal differentiation in PC12 cells (23, 26, 39, 40). To analyze
JNK activity, we quantified phosphorylation levels via Western
blotting (Fig. 1B). We found increased JNK activation begin-
ning at 1 h after treatment, with a maximum at about 2 h. Total
JNK levels did not change significantly. Western blot results
also showed that both JNK isoforms (p54 and p46) were
phosphorylated in response to NGF. In summary, these re-
sults confirm that JNK activity is required for neurite out-
growth and establish PC12 cells as a model for the study of
NGF-induced JNK-dependent signaling via SILAC-based
quantitative mass spectrometry.
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FIG. 1. NGF treatment leads to JNK-dependent neurite forma-
tion in PC12 cells. A, treatment with NGF (100 ng/ml) induces a major
shift in the phenotype of PC12 cells from proliferating tumor cells to
non-dividing neurons showing growth of neurites at 6 h after stimu-
lation. Pretreatment with the JNK inhibitor SP600125 (10 M) for 1 h
led to a significant decrease in neurite outgrowth. **p  0.01, ***p 
0.001 versus unstimulated or NGF treated (n  3 each). Scale bar: 20
m. B, neurite outgrowth was accompanied by NGF-induced JNK
phosphorylation (3-fold increase) peaking 2 h after NGF treatment.
NGF treatment had no effect on total JNK levels. Arrows indicate the
two different p54 and p46 JNK isoforms. **p  0.01 versus unstimu-
lated (n  4 to 7).
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JNK Interacts with Proteins of Different Molecular Functions
during Neuronal Differentiation—Phosphoproteomics is a
powerful approach for the study of cellular signal transduction
(41). However, in the case of JNK, this strategy is complicated
by several factors. First, the consensus JNK phosphorylation
site is a typical proline-directed phosphorylation motif shared
by several other kinases such as ERK1/2 and cyclin-depen-
dent kinases. Second, it has been shown that JNK sites can
also be phosphorylated by other kinases (6). These two fac-
tors make it difficult to discern JNK substrates from sub-
strates of other kinases in a classical phosphoproteomic ex-
periment. Finally, focusing exclusively on JNK substrates
would not provide any information about upstream signaling
events that lead to JNK activation. Because of these limita-
tions, we pursued an alternative proteomic approach. We
took advantage of the fact that JNK physically associates with
effectors via a docking site, the so-called JNK binding domain
(JBD). JBDs mediate the interaction of JNK with substrates,
as well as with adaptor proteins and upstream activators (6).
Therefore, studying dynamic changes in JNK interaction part-
ners can provide insights into both upstream and downstream
signaling events.
Our experimental strategy was to precipitate JNK from
stimulated PC12 cells and characterize dynamic changes in
the JNK interactome via SILAC-based quantitative shotgun
proteomics (Fig. 2A). Metabolic labeling of PC12 cells with
either “medium” (Lys-4, Arg-6) or “heavy” (Lys-8, Arg-10)
SILAC media for six passages resulted in essentially complete
labeling (data not shown). Labeled cells were then treated
with NGF for different lengths of time. To cover the dynamic
changes in JNK-associated proteins, we performed three par-
allel triple SILAC experiments with one time point as an inter-
nal reference. This procedure allows analysis of temporal
changes of the interactome (42). Cells were lysed, and JNK
and associated proteins were immunoprecipitated with bead-
coupled JNK1- and JNK2-specific antibodies. Immunopre-
cipitates from the three corresponding SILAC states were
combined, washed, and analyzed via high-resolution quanti-
tative shotgun proteomics. Protein data from the three time-
series measurements were combined into a single time
course using the common 2-h time point as a reference (i.e.
by calculating the ratio of ratios). To further increase the
robustness of the data, we combined data from two inde-
pendent biological replicates, and only proteins that were
quantified with at least three SILAC ratio counts at each time
point were considered. This analysis resulted in a list of 728
proteins. The list of identified proteins was expected to con-
tain three different groups of proteins: (i) NGF-regulated JNK
interaction partners, (ii) constitutive JNK interactors, and (iii)
nonspecific contaminants. As our aim was to assess the role
of JNK in NGF-induced neurite outgrowth, we focused our
analysis on only the first group. To extract potential NGF-
regulated interaction partners, we selected all proteins with a
log2 fold change  0.7 and/or  0.7 at any time point (n 
201) (supplemental Table S1). We then used hierarchical clus-
tering to classify these proteins according to their dynamic
behavior. The abundance profiles of proteins fell into three
major clusters (Fig. 2B).
The first cluster contained proteins that showed increased
abundance at both 0.5 to 1 h and 24 h of NGF stimulation with
transiently decreased levels between 2 and 6 h. This cluster
mainly contained actin-binding cytoskeletal proteins such as
tropomodulin-2, tropomyosin -4 chain, and several mem-
bers of the myosin family involved in cytoskeleton reorgani-
zation and ATP-dependent movement along microfilaments.
Furthermore, the motor protein kinesin light chain was found
in this cluster, which is in line with previous studies demon-
strating that JNK is involved in kinesin-dependent transport
processes and microtubule dynamics in neurons (11, 13, 43).
The third cluster contained proteins that belonged to the
families of large G-proteins and small GTPases including gua-
nine nucleotide-binding protein G(o) subunit , guanine nu-
cleotide-binding protein G(i) subunit -2, Rap1b, Rac1, RhoA,
and Cdc42. These proteins showed increased levels 0.5 h to
2 h after NGF treatment followed by a steady decrease over
time below control levels at 24 h. This finding suggests that
NGF-dependent JNK activation might be induced via multiple
G-proteins. Indeed, it has been shown that several G-proteins
are involved in JNK activation during PC12 cell differentiation
(25, 26) and that Rap1 is involved in NGF-induced PC12 cell
differentiation (44, 45).
The second cluster contained proteins that showed delayed
association with JNK starting 2 to 24 h after NGF stimulation.
We were surprised to find that this cluster was strongly en-
riched in RNA binding proteins. For example, this subset
contained proteins involved in mRNA splicing such as Fus
and SF1 (46) and RNA helicases such as Ddx-1, -5, and -17.
Intriguingly, two mRNA binding proteins in this cluster showed
transient JNK binding at 2 to 3 h of stimulation. This kinetic
behavior is similar to the activation profile of JNK (Fig. 1B).
These two proteins, namely, non-POU domain-containing oc-
tamer-binding protein (Nono) and splicing factor proline- and
glutamine-rich (Sfpq), are components of mRNA transport
granules in dendrites (47). Additionally, we identified paras-
peckle component 1 (Pspc1) in the cluster. Pspc1 is a paral-
ogue of Nono and a known component of neuronal transport
granule protein (47). Pspc1, Nono, and Sfpq are the three
mammalian members of the Drosophila behavior and human
splicing (DBHS) family involved in different aspects of RNA
biology (48, 49). As components of paraspeckles and neuro-
nal granules, they are found in the nucleus and in the cytosol,
respectively. DBHS proteins have been linked to neuronal
function. Sfpq mediates neuronal development in zebrafish,
and Nono is required for normal vision and courtship behavior
in fruit flies (50, 51).
D-JNKI-1 Specifically Blocks NGF-induced Neurite Out-
growth and Interaction of JNK with RNA-binding Proteins—
Next, we asked whether NGF-mediated interactions are me-
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FIG. 2. Quantitative mass spectrometry timecourse analysis of potential JNK interacting proteins after NGF treatment. A, PC12 cells
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diated by JBDs. To this end, we used the peptide inhibitor
D-JNKI-1, which blocks interaction of JNK with its substrates
(52). D-JNKI-1 consists of the protease-resistant D-retroin-
verso form of a 10-amino-acid HIV-Tat sequence, which al-
lows for cellular uptake, and the 20-amino-acid sequence of
the JBD of JNK interacting protein 1 (53–55). Thus, D-JNKI-1
specifically blocks interactions of JNK mediated by JBDs.
D-JNKI-1 has been shown to be highly specific and has been
used to block JNK activity in several neuronal disease model
systems (56–58).
To see whether D-JNKI-1 blocks NGF-induced neurite out-
growth, we pretreated PC12 cells with D-JNKI-1 for 1 h.
D-JNKI-1 dose-dependently decreased NGF-induced neurite
outgrowth as assessed 24 h after stimulation (Fig. 3A). The
inhibitory effect of D-JNKI-1 at a concentration of 10 M was
60%, which is comparable to the inhibitory effect of the ATP
competitive inhibitor SP600125 at the same concentration.
Pretreatment with the control peptide D-TAT alone had no
effect on NGF-induced neurite outgrowth, indicating that the
inhibitory effect of D-JNKI-1 on neurite outgrowth is JNK
specific. Additionally, we tested the inhibitory effect of D-
JNKI-1 via phospho-specific Western blot analysis of the
major JNK downstream target c-Jun. As expected, D-JNKI-1
(10 M) significantly inhibited NGF-induced c-Jun phosphor-
ylation at 3 h after NGF treatment (data not shown). These
results corroborate our previous findings and suggest that
JNK interaction with its substrates is necessary for NGF-
induced neurite outgrowth.
To investigate the effect of D-JNKI-1 on the JNK interac-
tome, we focused on 3-h NGF stimulation, as this time point
coincides with high JNK activation. Light cells were left un-
treated, medium-heavy cells were pretreated for 1 h with
D-JNKI-1 (10 M), and heavy cells were pretreated with the
control peptide D-TAT. Both medium-heavy and heavy cells
were then stimulated with NGF for 3 h (Fig. 3B). JNK was
precipitated from all three cell populations, and JNK-associ-
ated proteins were identified via mass spectrometry as de-
scribed above. As a control we analyzed supernatants from
the immunoprecipitations, and we did not observe global
effects of NGF or D-JNKI-1 on the PC12 proteome (supple-
mental Fig. S1A). For JNK-associated proteins, we plotted
ratios of NGFD-TAT treated samples versus unstimulated
samples (x-axis) and of NGFD-TAT treated samples versus
NGFD-JNKI-1 treated samples (y-axis) against each other
(Fig. 3C). The resulting plot shows which proteins interacted
with JNK in an NGF- and/or D-JNKI-1-dependent manner.
We found that NGF-induced and D-JNKI-1-inhibited
interactions were clearly correlated. Specifically, most of the
NGF-induced interactions were inhibited by D-JNKI-1. Thus,
NGF-induced interactions seem largely JBD dependent. In-
terestingly, interactors fell into two groups. The first group
was strongly NGF dependent and moderately affected by the
inhibitor (highlighted in green in Fig. 3C). This set of proteins
was enriched in actin-binding cytoskeletal proteins such as
drebrin, a protein that is involved in axonal growth (59). This
subset also included filamin-B, an actin regulatory protein that
has been described as a JNK scaffold protein that tethers
Rac1 and a JNK-specific module (60). The second group of
proteins was strongly inhibited by D-JNKI-1 and showed a
moderate response to NGF (highlighted in red in Fig. 3C). This
group contained the above-mentioned DBHS family proteins
Sfpq, Nono, and Pspc1 and several other known components
of RNA transport granules (Pur  and Pur , several FMRPs,
DDX1, DDX5, DDX6, and DDX17). To test whether other pro-
teins in our dataset were also involved in RNA transport, we
compared our data to a proteomic analysis of RNA transport
granules (47). 26 out of 42 RNA transport granule proteins
from a study by Kanai et al. were found in our dataset (sup-
plemental Fig. S1B), and 18 out of these 26 were classified as
JNK-specific interaction partners (log2 fold change  0.7).
This is a highly significant enrichment (p  2.81E-07, hy-
pergeometric test) for mRNA transport granule proteins in the
NGF- and D-JNKI-1-dependent JNK interactome. In sum-
mary, our experiments with the JNK-specific blocking peptide
D-JNKI-1 confirm that JNK interacts with cytoskeletal proteins
and RNA transport granule proteins in an NGF-dependent
manner. The interactions can be specifically blocked with
D-JNKI-1 and are thus apparently mediated by JBDs. JNK
interacting proteins from this experiment are listed in supple-
mental Table S2.
JNK1 Interacts with the Nono–Sfpq Heterodimer in an RNA-
dependent Way—To the best of our knowledge, the interac-
tion of JNK with RNA transport granule proteins had not been
described at the time of this study. We therefore performed
follow-up experiments to validate and further characterize this
observation. First, we sought to validate the mass spectrom-
etry data via immunoprecipitation and Western blotting. We
observed that JNK1 co-immunoprecipitated with Sfpq, Nono,
and Pspc1 (Fig. 4A). Whereas NGF treatment increased the
interaction, pretreatment of cells with D-JNKI-1 decreased the
NGF-induced interaction to baseline levels. These results
confirm that (i) JNK interacts with DBHS family proteins in
PC12 cells, (ii) the interaction is increased by NGF stimulation,
and (iii) the interaction is JBD dependent.
Although co-immunoprecipitation of endogenous proteins
is considered the gold-standard assay for protein–protein
analyzed with MaxQuant. Proteins with a log2 fold change  0.7 and/or log2 fold change  0.7 at any time point given were extracted and
z-scored. Proteins with similar JNK binding kinetics were clustered using Perseus software (Euclidean distance, average linkage, n  201).
Analysis of the molecular function of potential JNK interacting proteins using Protein Analysis through Evolutionary Relationships (PANTHER)
revealed an enrichment for cytoskeletal protein (cluster 1, n  25), nucleic acid binding (cluster 2, n  73) and G-proteins (cluster 3, n  104).
The three most significant PANTHER terms per cluster are shown.
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FIG. 3. The JNK-specific peptide inhibitor D-JNKI-1, which blocks the interaction of JNK with its substrates, decreased NGF-induced
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interactions, it is still affected by possible antibody cross-
reactivities. To verify the specificity of the assay, we per-
formed the inverse experiment and used an antibody against
Nono for immunoprecipitation. In addition, we used RNase A
treatment to test whether the interactions were RNA depen-
dent. In these experiments we found that NGF treatment led
to a 2.5-fold induction of JNK1 binding to Nono (Fig. 4B).
RNase A treatment decreased the interaction, indicating that
it was RNA dependent. The interaction seemed to be specific
for JNK1, as JNK2 was not detected in the Nono pull-downs.
Sfpq was also observed to co-precipitate with Nono, and this
interaction was not affected by NGF or RNase A treatment.
This result is in line with a previous study demonstrating that
Nono and Sfpq form a stable, RNase-resistant, mRNA-
binding heterodimer in neurons (47). Collectively, these results
further confirm the interaction of JNK and mRNA transport
granule proteins and indicate that JNK1, rather than JNK2, is
the main interactor. Because we observed that the interaction
was RNA dependent, we suggest that JNK1 associates with
RNA-containing multi-protein complexes rather than with in-
dividual proteins.
NGF Treatment Induces JNK1 Interaction with Sfpq in the
Cytosol—DBHS family proteins and JNK can be found in the
nucleus and the cytosol. We therefore analyzed the subcellu-
lar distribution of Nono and Sfpq in PC12 cells via confocal
microscopy. Representative images of three independent ex-
periments showed that Nono and Sfpq were most abundant in
the nucleus but were also found in the cytosol of PC12 cells
(Fig. 5A, upper panel). This result was also confirmed by
Western blot analyses of cytosolic and nuclear fractions from
two independent experiments (Fig. 5B). NGF treatment for 3 h
did not significantly alter the distribution of the total cellular
Nono and Sfpq pools (Fig. 5B). To analyze the interaction of
JNK1 and Sfpq, we stained stimulated and unstimulated
PC12 cells with JNK1- and Sfpq-specific antibodies. Interest-
ingly, increased co-localization of JNK1 and Sfpq was ob-
served in outgrowing neurites of NGF-treated cells relative to
unstimulated cells (Fig. 5A, lower panel). Evaluation of JNK1
stained cells alone revealed that JNK1 was mainly expressed
in the cytosol of untreated and NGF-treated cells (Fig. 5A,
lower panel, arrowheads). Consistent results were obtained in
Western blots of cytosolic and nuclear extracts (Fig. 5B).
These results are also supported by a previous study showing
that JNK1 is mainly located in the cytosol in PC12 cells (61).
Similar to JNK1, JNK2 was mainly detected in the cytosol, but
it also showed considerable nuclear localization. NGF-in-
duced phosphorylation of both JNK isoforms occurred mainly
in the cytosol (Fig. 5B).
Unbiased assessment of changes in protein co-localization
via microscopy is challenging. Therefore, to confirm the in-
creased co-localization of JNK1 and Sfpq, we employed the
proximity ligation assay (PLA) (62). PLA uses the enzymatic
ligation of connector oligonucleotides that are attached to
different antibodies and rolling circle amplification to increase
the signal derived from individual interactions. With this
method one can detect the co-localization of endogenous
proteins in an unbiased and quantitative manner. As a positive
control, we tested the interaction of Nono and Sfpq. Evalua-
tion of PLA signals in cells co-stained with DAPI revealed that
the Nono–Sfpq heterodimer was located mainly in the nucleus
and to a minor extent in the cytosol (Fig. 6A). Next, we used
PLA to quantify the co-localization of JNK1 and Sfpq (Fig. 6B).
Quantitative analysis of PLA signals revealed that NGF treat-
ment led to a significant induction (5-fold) of JNK1–Sfpq
interaction. In line with our previous findings, PLA signals of
the JNK1–Sfpq interaction in NGF-treated cells were mainly
observed in the cytosol, whereas JNK1–Sfpq interaction in
unstimulated cells was found in the nucleus. Together, these
results indicate that the Nono–Sfpq heterodimer is mainly
located in the nucleus, but JNK1 interacts with Nono–Sfpq in
an NGF-dependent manner mainly in the cytosol.
JNK1 and Sfpq Transiently Co-localize in Primary Cortical
Neurons and P19 Neuronal Cells—To further study the asso-
ciation of JNK1 and Sfpq in the cytosol of differentiating
neurons, we made use of two additional neuronal models, (i)
mouse primary cortical neurons and (ii) neurons derived from
the murine embryonic carcinoma cell line P19. Primary corti-
cal neurons spontaneously form neurites after plating, con-
tinuing in vitro their differentiation process (28). P19 cells
differentiate into neurons upon treatment with retinoic acid
and produce numerous neurites similar to primary cortical
neurons (63).
Confocal microscopy of primary cortical neurons and P19
neuronal cells revealed that JNK1 and Sfpq, like in PC12 cells,
were present in the nucleus and in the cytosol, particularly
during the first 12 h of differentiation, which coincides with the
polarization and outgrowth of primary neurites in both neuro-
nal models (Figs. 7A–7C and 7E–7G; arrowheads in insets
7A	–7C	 and 7E	–7G	). Confocal images showed that JNK1
was mainly localized in the cytosol (Figs. 7A
–7H
), whereas
Sfpq localized in the cytosol only during the polarization and
outgrowth of primary neurites (Figs. 7A–7H). At later stages,
Sfpq was found exclusively in the nucleus (Figs. 7D, 7H, 7D,
and 7H). Quantification of neurons stained for JNK1 and
Sfpq revealed a maximal co-localization of both molecules in
the cytosol of immature neurons during the first 12 h of
analyzed via LC-MS/MS. C, 701 proteins were quantified with at least three ratio counts. PANTHER analysis showed an enrichment for
cytoskeletal proteins (n  65) and nucleic acid binding proteins (n  94), which specifically co-immunoprecipitated with JNK after NGF
treatment. A log2 fold change of 0.7 was applied as a cutoff. The three most significant PANTHER terms per cluster are shown. Highlighted
proteins are discussed in the “Results” section.
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neuronal differentiation, whereas no co-localization was ob-
served after 24 h (Fig. 7I).
Together, these results are consistent with the data obtained
from PC12 cells. The fact that transient co-localization of JNK1
and Sfpq occurred in the same subcellular location and with
similar kinetics in three distinct neuronal models strongly sug-
gests that interaction of JNK with RNA transport granules is a
generic feature during neuronal differentiation (Fig. 7J).
Sfpq Contributes to NGF-induced Neurite Outgrowth in
PC12 Cells—To further investigate whether the JNK interac-
tion partner Sfpq is involved in neuronal differentiation, we
treated PC12 cells with Sfpq siRNA for 4 days. Western blot
results for PC12 whole cell lysates showed that Sfpq was
dose-dependently knocked down (Fig. 8A). Semi-quantitative
analysis of band intensities revealed that knockdown efficiency
was almost complete (97%) at a dose of 200 nmol siRNA. We
then treated Sfpq knockdown cells with NGF (100 ng/ml) and
measured neurite outgrowth 24 h after stimulation (Fig. 8B).
Sfpq knockdown led to a significant decrease (50%) in NGF-
induced neurite outgrowth, demonstrating that Sfpq is involved
in the neuronal differentiation of PC12 cells. In parallel, we
pretreated mock-transfected or Sfpq siRNA transfected cells
with JNK inhibitor SP600125 (10 M) for 1 h before NGF stim-
ulation. SP600125 significantly decreased NGF-induced neurite
outgrowth by 60% in mock-transfected cells. Thus, Sfpq
knockdown and JNK inhibition have a similar effect on neurite
outgrowth. Interestingly, treating cells with both SP600125 and
Sfpq siRNA did not further increase the inhibition of neurite
outgrowth. The lack of a cumulative effect is consistent with the
hypothesis that JNK and Sfpq mediate NGF-induced neurite
outgrowth via the same pathway and that interaction between
JNK and RNA transport granule proteins is involved in neuronal
differentiation.
DISCUSSION
Signal transduction cascades are typically represented as
graphs that begin with the activation of a cell surface receptor
and end with the activation of a transcription factor. How-
ever, it is now clear that gene expression is also regulated at
the posttranscriptional level. For example, microRNAs and
RNA binding proteins interact with mRNAs and control their
splicing, export, stability, localization, and translation (64,
65). In fact, translation efficiency appears to be the single
best predictor of cellular protein abundance (66). Posttran-
scriptional regulation is particularly relevant in highly com-
partmentalized cells such as neurons, where specific func-
tions occur in restricted subcellular domains (67). Although
the link between signaling cascades and transcriptional
control is quite well studied, the connections between cell
signaling and posttranscriptional regulatory events are still
poorly characterized.
It is known that JNKs play an important role in both neuro-
nal cell death and neuronal differentiation (5–8). Whereas
apoptosis induction appears to depend on nuclear JNK, cy-
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FIG. 4. JNK1 interacts with the Nono–Sfpq heterodimer in a
D-JNKI-1- and RNA-dependent way in NGF-treated PC12 cells. A,
JNK1 was immunoprecipitated from whole cell lysates in unstimu-
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D-JNKI-1. Western blots against Nono, Sfpq, and Pspc1 showed that
D-JNKI-1 decreased NGF-induced interaction of JNK1 with these
proteins. A representative blot is shown. B, Nono was immunopre-
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Western blots showed a2.5-fold increase in JNK1–Nono interaction
after 3 h of NGF treatment, which was inhibited by RNase A treatment
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JNK2 band p54. PC12 whole cell lysate (WCL) was used as a positive
control.
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tosolic JNK activity is required for neurite outgrowth (5, 11).
Here, we have shown that JNK dynamically associates with
RNA binding proteins in an early phase during neuronal dif-
ferentiation. First, we showed that JNK activity is required for
NGF-induced neurite outgrowth, consistent with previous re-
ports (23, 24). We then used quantitative interaction proteo-
mics to identify proteins associating with JNK in an NGF-de-
pendent manner. Surprisingly, we observed that several
RNA-binding transport granule proteins including Nono, Sfpq,
and Pspc1 temporally associated with JNK. We validated the
specificity of these interactions by showing that they could be
blocked by D-JNKI-1, a highly specific peptide inhibitor of
JNK. Moreover, we used Western blotting to show that Nono,
Sfpq, and Pspc1 co-precipitate with JNK1 but not JNK2 in an
RNA-dependent manner. Using fractionation experiments,
confocal microscopy, and proximity ligation assay, we found
that this interaction mainly occurred in the cytosol of differ-
entiating PC12 cells. Importantly, we were able to replicate
our findings in P19-derived and primary neurons, strongly
suggesting that the interaction is a generic feature of neuronal
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differentiation. The fact that the temporal interaction was ob-
served during the early stages of neurite extension suggests
that this interaction might play a role in the initiation of post-
transcriptional gene regulation events.
Nono, Sfpq, and Pspc1 are the mammalian members of the
DBHS family involved in many aspects of RNA biology (48,
49). Most research on these proteins so far has focused on
their role in the nucleus, where they are components of sub-
nuclear bodies termed paraspeckles. Although the function of
paraspeckles is not well understood, they have been reported
to retain mRNAs in the nucleus to allow their rapid release into
the cytosol upon stress (68). In neuronal cells, all three pro-
teins have been described as components of RNA transport
granules (47). Sfpq has been shown to be involved in neuronal
development in zebrafish (50), and we show here that knock-
ing down Sfpq impaired neurite outgrowth. Nono is required
for normal vision and courtship behavior in fruit flies (51).
Thus, DBHS proteins have neuronal functions in vivo. We
observed that JNK1 interacted with Sfpq in the cytosol of
PC12 cells. Therefore, our data suggest that JNK1 mediates
neuronal differentiation at least partially via interaction with
DBHS family proteins in the cytosol. Interestingly, we found
that the NGF-induced interaction of JNK1 with Nono/Sfpq
was RNA-dependent. This suggests that JNK1 associates
with entire transport granules in an NGF-dependent manner.
In fact, the NGF-induced JNK interactome was strongly en-
riched in known components of RNA transport granules. It
should therefore be stressed that we have no evidence that
JNK1 is a direct binder of Sfpq and/or Nono. In fact, given that
the interaction was RNA dependent, it appears more likely
that JNK1 associates with higher order complexes containing
these proteins and RNAs, possibly via its low-complexity
region (see below). Both JNK and neuronal granule proteins
are known to be involved in neuronal differentiation. However,
to the best of our knowledge, a link between JNK signaling
and neuronal granules has not yet been described.
RNA granules are particularly important in neurons for the
targeting of mRNAs to distinct cellular compartments for lo-
calized translation (67, 69). How proteins and RNAs are tar-
geted to and released from RNA granules is not yet entirely
understood. Recently, it has been reported that proteins can
assemble into RNA granules via low-complexity regions (70,
71). How this assembly and disassembly are regulated is
largely unknown. One possible mechanism involves phos-
phorylation. For example, the kinase DYRK3 has been
shown to interact with stress granules, presumably via a
low-complexity region (72). DYRK3 inhibition stabilizes the
granules, suggesting that this kinase can disassemble gran-
ules via the phosphorylation of specific target proteins.
Similar to DYRK3, JNK1 has a predicted low-complexity
region that is disordered in the crystal structure (73). It is
tempting to speculate that JNK1 might be involved in reg-
ulating transport granules. For example, granule-associated
JNK1 might phosphorylate substrate proteins in the gran-
ules to induce their release. As for DYRK3, these putative
JNK1 substrates remain to be identified. In addition to RNA
binding proteins, we found that JNK1 also interacted with
proteins involved in dendritic and/or axonal transport via
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microfilaments and microtubules (kinesin light chain, fil-
amin-B, and drebrin). It is therefore possible that JNK1
controls the transport of RNA granules. Consistently, JNK1
is known to control the phosphorylation of microtubule-
associated proteins and to be required for the maintenance
of neuronal microtubules (13).
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In summary, our unbiased proteomic analysis of the dy-
namic JNK interactome reveals that JNK dynamically associ-
ates with RNA transport granule proteins during neuronal
differentiation. Although the exact mechanisms involved in the
interaction of JNK with neuronal granules remain to be inves-
tigated, blocking the interaction with the highly selective pep-
tide D-JNKI-1 inhibits neurite outgrowth. Thus, interactions
mediated via JBDs appear to be functionally important for
neuronal differentiation. Furthermore, we show that Sfpq, a
member of RNA transport granules, is involved in neuronal
differentiation in PC12 cells. However, several important
questions remain. First, it is not known which RNAs are lo-
cated in the JNK-associated neuronal granules. Furthermore,
it might be informative to see which proteins are phosphory-
lated by JNK upon NGF treatment, although the identification
of direct kinase substrates in vivo is challenging. We also note
that several well-described JNK interaction partners such as
microtubule-associated protein, JNK interacting protein, and
c-Jun were not identified in our dataset. It is not clear whether
this is due to the specialized function of JNK in PC12 cells or
to limitations of our experimental approach. Finally, JNK is not
the only mediator of neuronal differentiation. How neurons
integrate different signaling events in a spatio-temporal man-
ner remains to be explored.
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